What is Ultherapy?
Ultherapy is a leader in non-invasive aesthetic treatments, offering a unique solution for skin lifting and tightening through micro-focused ultrasound energy. This technology stimulates the body's natural collagen production, providing a subtle yet noticeable lift for areas including the neck, brows, and under the chin. As an FDA-cleared procedure, Ultherapy is recognized as a Gold Standard in nonsurgical skin rejuvenation, achieving a remarkable 95% patient satisfaction rate one year post-treatment. The company's commitment to personalized care is evident in its use of real-time imaging, ensuring both safety and efficacy for individuals seeking surgical-free skin tightening solutions with results that can last up to a year.
How much funding has Ultherapy raised?
Ultherapy has raised a total of $38.5M across 3 funding rounds:
Series B
$22.5M
Series C
$10.5M
Series A
$5.5M
Series B (2008): $22.5M with participation from 3i Group and New Enterprise Associates
Series C (2011): $10.5M led by Apposite Capital and New Enterprise Associates
Series A (2020): $5.5M supported by 3i
Key Investors in Ultherapy
3i
3i is a prominent investment firm with a history of backing innovative companies across various sectors, likely focusing on growth-stage opportunities in technology and healthcare.
Apposite Capital
Apposite Capital is an investment firm that typically engages with companies in the healthcare and life sciences industries, suggesting a strategic interest in Ultherapy's medical technology.
New Enterprise Associates
New Enterprise Associates (NEA) is a globally recognized venture capital firm known for investing in technology and healthcare companies from early to growth stages, indicating a belief in Ultherapy's market potential and scalability.
What's next for Ultherapy?
With substantial enterprise-level funding and a recent major strategic investment, Ultherapy is poised for significant expansion. The company's focus will likely be on scaling its operational capacity, enhancing its technological offerings, and broadening its market reach both domestically and internationally. Further investment may also fuel research and development into new applications or improved treatment protocols, solidifying its dominance in the lucrative medical aesthetics market and reinforcing its reputation for delivering high-quality, non-surgical cosmetic enhancements.
See full Ultherapy company page
